Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis [NA]
Clinical trial update for the OPUS YOUNG study comparing early intervention versus treatment as usual for adolescents with first-episode psy…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Schizophrenia Cognition Scale Development
Completed a clinical trial focused on developing a cognition assessment scale for schizophrenia.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Promoting Cognitive Health in Schizophrenia [NA]
A clinical trial update announcing recruitment to promote cognitive health in individuals with schizophrenia.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders [NA]
An ongoing clinical trial evaluating cognitive remediation to improve social cognition in schizophrenia and related psychotic disorders, cur…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia [NA]
A clinical trial exploring salutogenic-based interviewing in schizophrenia is sponsored by Ataturk University and aims to assess subjective …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Sex, Psychopharmacology, and Diabetes [NA]
A recruiting clinical trial sponsored by Zealand University Hospital is investigating sex, psychopharmacology, and diabetes in individuals w…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: MonPsy&Moi: A Digital Platform for Collecting Patient-Reported Experience and Outcome Measures in Psychiatry
Clinical trial update describing MonPsy&Moi, a digital platform to collect patient-reported experiences and outcomes in psychiatry, sponsore…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Cognitive Training for Emotion Regulation in Psychotic Disorders [NA]
This clinical trial status update shows recruitment ongoing for a cognitive training program intended to improve emotion regulation in psych…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Effects of Aerobic Exercise, Cognitive Remediation and Combined Intervention in Schizophrenia [NA]
This clinical trial update notes the completion of a study evaluating aerobic exercise, cognitive remediation, and a combined intervention i…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )
A completed clinical trial evaluating the implementation of a tool to reduce cardiovascular risk in patients with schizophrenia and related …
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Patientheque in Patients With a Psychosis . [NA]
A clinical trial called Patientheque is recruiting patients with schizophrenia, including prodromal and childhood-onset forms, at University…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: The Effect of Acceptance and Commitment Therapy Intervention on Caregiver Burden in Caregivers of Schizophrenia Patients [NA]
A clinical trial update from Cumhuriyet University evaluating whether Acceptance and Commitment Therapy reduces caregiver burden in caregive…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Study on the Efficacy and Safety of QLM1016 in Schizophrenia [Phase 3]
This document reports a Phase 3 clinical trial evaluating the efficacy and safety of QLM1016 for schizophrenia, currently not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: A Register Study of Effects Following Local Variation in Rates of Involuntary Care
A register study assessing outcomes after local variation in involuntary care rates among people with schizophrenia and bipolar disorder; th…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Treating Schizophrenia by Correcting Abnormal Brain Development [Phase 3]
A Phase 3 clinical trial led by Beth Israel Deaconess Medical Center is investigating a treatment for schizophrenia that aims to correct abn…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Effect of Food and Age on the Pharmacokinetics of LY03017 [Phase 1]
This update describes a Phase 1 pharmacokinetic study of LY03017 evaluating the effects of food and age on its pharmacokinetics.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental application for aripiprazole (ARIPIPRAZOLE) under the ANDA pathway.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for aripiprazole from Alembic Pharmaceuticals, enabling the marketing of a generic version. This…
-
FDA approval · 2025-01-24FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved a supplemental application for Fluphenazine hydrochloride by Zydus Pharmaceuticals (USA) Inc., indicating approval of changes t…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole, authorizing a generic ARIPIPRAZOLE product with the same in…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application from Apotex Corp. for aripiprazole (ANDA204094), authorizing changes to the generic product's approv…
-
FDA approval · 2025-01-24FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)
FDA approved a supplemental application for Perseris (risperidone) filed by Indivior Inc. Perseris is a long-acting injectable antipsychotic…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for aripiprazole oral from Camber Pharmaceuticals, resulting in approval of this generic product's l…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for aripiprazole from VistaPharm, LLC, for a generic aripiprazole product.